HOME >> BIOLOGY >> NEWS
Muscle loss from space travel, prolonged inactivity linked to two genes

(Boston) -- In research that could benefit astronauts posted to the International Space Station as well as individuals whose universe is defined by their sick bed, Boston University Sargent College researchers Susan Kandarian and R. Bridge Hunter have found that disrupting either one of two genes, nfb1 and bcl3, can block the biological process of muscle wasting known as atrophy.

Their findings will inform efforts to identify therapeutics that could inhibit muscle atrophy caused by a chronic reduction in muscle use. Such treatments could end the muscle loss, weakness, and fatigue that can plague space travelers, sedentary or bed-ridden individuals, or anyone whose muscles undergo long periods of disuse.

"By understanding the genes necessary for muscle atrophy," says Kandarian, lead researcher and professor of health sciences at BU Sargent College of Health and Rehabilitation Sciences, "we can begin to study the protein products required for atrophy. Our ongoing research shows that the process of atrophy might be partially moderated by something as straightforward as aspirin or other non-steroidal anti-inflammatory drugs [NSAIDs]."

It is well known that prolonged muscle disuse causes muscles to lose protein in two ways: by decreasing the amount of protein synthesized and by increasing the rate at which muscle protein is degraded. The intracellular signals that drive muscle protein to these extremes, however, are not well known.

When designing her study, Kandarian chose to investigate the role of nfb1 and bcl3, two gene members from a family of transcription factors -- genes that produce proteins that regulate the activities of other genes. Her previous research had shown these transcriptional regulators were implicated in the process of muscle atrophy.

By studying strains of mice bred to be without the nfb1 gene or without the bcl3 gene, so-called knockout mice
'"/>

Contact: Ann Marie Menting
amenting@bu.edu
617-358-1240
Boston University
16-Nov-2004


Page: 1 2 3

Related biology news :

1. Muscle weakness: New mutation identified
2. Muscle and bone from an ink-jet printer
3. Muscle of obese programmed to amass fat, genetic study finds
4. Muscle repair: Making a good system better, faster; implications for aging, disease
5. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
6. Muscle-building hand-grips aid systolic blood pressure, carotid AD, endothelial function
7. Envisat captures first image of Sargassum from space
8. Counting heads or measuring space?
9. Prototype space probe prepares to explore Earths deepest sinkhole
10. West Antarcticas subglacial plumbing system mapped from space
11. Walking tall: UH student working on space suit redesign for NASA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2020)... ... March 13, 2020 , ... Cryo-Cell International’s announcement is ... performed by Dr. Hal Boxmeyer and colleagues, which determined sample viability of 23.5 ... under proper conditions. Cryo-Cell International marks the first family cord blood bank to ...
(Date:3/13/2020)... ... March 13, 2020 , ... ... Vivorte Inc. to be the exclusive distributor of the Louisville-based company’s orthobiologics portfolio. ... medical education expertise to distribute Vivorte’s calcium phosphate-based bone allograft (Trabexus) and calcium ...
(Date:3/11/2020)... ... March 11, 2020 , ... Polysense Technologies Inc., (Polysense) ... body temperature infrared touch-free monitoring product family, a standalone thermal meter WxS x800-IRTMS, ... wireless uplink for cloud connectivity such as NB-IoT, Wi-Fi, LoRaWAN, and 4G LTE, ...
Breaking Biology News(10 mins):
(Date:4/1/2020)... ... March 31, 2020 , ... ... a method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that decreases ... volumes, increased samples per run, and standard, affordable laboratory equipment, a qualitative ...
(Date:3/19/2020)... ... March 17, 2020 , ... ... gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical translation ... indications. The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) bioprocess ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... chain biopharmaceutical engineering firm, is pleased to announce the addition of Carson ... medical device qualification and validation in the biopharmaceutical cold chain. He provides ...
(Date:3/3/2020)... ... March 03, 2020 , ... Ideal ... the latest breast implant technology at the IMCAS Innovation Shark Tank 2020 in ... the dermatology, plastic surgery, and aesthetic science industries that promise to revolutionize medical ...
Breaking Biology Technology:
Cached News: